Cognitive Deficits in Schizophrenia and Alcoholism: A Review of the Evidence and Findings on the Effects of Treatment on Cognitive Functioning in Patients With Dual Diagnoses

REFERENCES

• Allen , D. N. , Goldstein , G. and Aldarondo , F. 1999 . Neurocognitive dysfunction in patients diagnosed with schizophrenia and alcoholism . Neuropsychology , 13 ( 1 ) : 62 – 68 . doi: 10.1037/0894-4105.13.1.62
   PubMed Web of Science ®Google Scholar
• Allen , D. N. , Goldstein , G. , Forman , S. D. , Keshavan , M. S. , van Kammen , D. P. and Sanders , R. D. 2000 . Neurologic examination abnormalities in schizophrenia with and without a history of alcoholism . Neuropsychiatry, Neuropsychology, and Behavioral Neurology , 13 ( 3 ) : 184 – 187 . Retrieved from http://journals.lww.com/cogbehavneurol/pages/default.aspx
   PubMedGoogle Scholar
• Allen , D. N. , Goldstein , G. and Mariano , E. 1999 . Is the Halstead Category Test a multidimensional instrument? . Journal of Clinical and Experimental Neuropsychology , 21 ( 2 ) : 237 – 244 . doi: 10.1076/jcen. 21.2.237.926
   PubMed Web of Science ®Google Scholar
• Allen , D. N. and Remy , C. J. 2000 . Neuropsychological deficits in patients with schizophrenia and alcohol dependence . Archives of Clinical Neuropsychology , 15 : 762 – 763 . Retrieved from http://acn.oxfordjournals.org/content/15/8/762.2.full.pdf
   Web of Science ®Google Scholar
• Allen , D. N. , Strauss , G. P. , Donohue , B. and Van Kammen , D. P. 2007 . Factor analytic support for social cognition as a separable cognitive domain in schizophrenia . Schizophrenia Research , 93 ( 1–3 ) : 325 – 333 . doi: 10.1016/j.schres.2007.02.008
   PubMed Web of Science ®Google Scholar
• Altshuler , L. L. , Ventura , J. , van Gorp , W. G. , Green , M. F. , Theberge , D. C. and Mintz , J. 2004 . Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects . Biological Psychiatry , 56 ( 8 ) : 560 – 569 . doi: 10.1016/j.biopsych.2004.08.002
   PubMed Web of Science ®Google Scholar
• Ambrose , M. L. , Bowden , S. C. and Whelan , G. 2001 . Thiamin treatment and working memory function of alcohol-dependent people: Preliminary findings . Alcoholism: Clinical & Experimental Research , 25 ( 1 ) : 112 – 116 . doi: 10.1111/j.1530-0277.2001.tb02134.x
   PubMed Web of Science ®Google Scholar
• Arnsten , A. F. , Cai , J. X. , Murphy , B. L. and Goldman-Rakic , P. 1994 . Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys . Psychopharmacology , 116 ( 2 ) : 143 – 151 . doi: 10.1007/BF02245056
   PubMed Web of Science ®Google Scholar
• Barch , D. M. , Braver , T. S. , Carter , C. S. , Poldrack , R. A. and Robbins , T. W. 2009 . CNTRICS final task selection: Executive control . Schizophrenia Bulletin , 35 ( 1 ) : 115 – 135 . doi: 10.1093/schbul/sbn154
   PubMed Web of Science ®Google Scholar
• Beer , J. S. and Ochsner , K. N. 2006 . Social cognition: A multi level analysis . Brain Research , 1079 ( 1 ) : 98 – 105 . doi: 10.1016/j.brainres.2006.01.002
   PubMed Web of Science ®Google Scholar
• Bora , E. , Yucel , M. and Pantelis , C. 2010 . Cognitive impairment in schizophrenia and affective psychoses: Implications for DSM-V criteria and beyond . Schizophrenia Bulletin , 36 ( 1 ) : 36 – 42 . doi: 10.1093/schbul/sbp094
   PubMed Web of Science ®Google Scholar
• Bowie , C. R. , Serper , M. R. , Riggio , S. and Harvey , P. D. 2005 . Neurocognition, symptomatology, and functional skills in older alcohol-abusing schizophrenia patients . Schizophrenia Bulletin , 31 ( 1 ) : 175 – 182 . doi: 10.1093/jschbul/sbi001
   PubMed Web of Science ®Google Scholar
• Bradley , S. R. , Lameh , J. , Ohrmund , L. , Son , T. , Bajpai , A. , Nguyen , D. and Bonhaus , D. W. 2010 . AC-260584, an orally bioavailable M(1) muscarinic receptor allosteric agonist, improves cognitive performance in an animal model . Neuropharmacology , 58 ( 2 ) : 363 – 373 . doi: 10.1016/j.neuropharm.2009.10.003
   Web of Science ®Google Scholar
• Buchanan , R. W. , Freedman , R. , Javitt , D. C. , Abi-Dargham , A. and Lieberman , J. A. 2007 . Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia . Schizophrenia Bulletin , 33 ( 5 ) : 1120 – 1130 . doi: 10.1093/schbul/sbm083
   PubMed Web of Science ®Google Scholar
• Cantor-Graae , E. , Nordstrom , L. G. and McNeil , T. F. 2001 . Substance abuse in schizophrenia: A review of the literature and a study of correlates in Sweden . Schizophrenia Research , 48 ( 1 ) : 69 – 82 . doi: 10.1016/S0920-9964(00)00114-6
   PubMed Web of Science ®Google Scholar
• Choca , J. P. , Laatsch , L. and Agresti , A. 1997 . The Halstead Category Test: A fifty year perspective . Neuropsychology Review , 7 ( 2 ) : 61 – 75 . doi: 10.1023/B:NERV.0000005944.98635.16
   PubMed Web of Science ®Google Scholar
• Cook , C. C. , Hallwood , P. M. and Thomson , A. D. 1998 . B Vitamin deficiency and neuropsychiatric syndromes in alcohol misuse . Alcohol and Alcoholism , 33 ( 4 ) : 317 – 336 . Retrieved from http://alcalc.oxfordjournals.org/
   PubMed Web of Science ®Google Scholar
• Cuffel , B. J. 1992 . Prevalence estimates of substance abuse in schizophrenia and their correlates . Journal of Nervous & Mental Disease , 180 ( 9 ) : 589 – 592 . discussion 593–596. doi: 10.1097/00005053-199209000-00008
   PubMed Web of Science ®Google Scholar
• Duke , P. J. , Pantelis , C. and Barnes , T. R. 1994 . South Westminster schizophrenia survey. Alcohol use and its relationship to symptoms, tardive dyskinesia and illness onset . British Journal of Psychiatry , 164 : 630 – 636 . doi: 10.1192/bjp.164.5.630
   PubMed Web of Science ®Google Scholar
• Fields , R. B. , Van Kammen , D. P. , Peters , J. L. , Rosen , J. , Van Kammen , W. B. , Nugent , A. and Linnoila , M. 1988 . Clonidine improves memory function in schizophrenia independently from change in psychosis . Schizophrenia Research , 1 ( 6 ) : 417 – 423 . doi: 10.1016/0920-9964(88)90024-2
   PubMed Web of Science ®Google Scholar
• Fioravanti , M. , Carlone , O. , Vitale , B. , Cinti , M. E. and Clare , L. 2005 . A meta-analysis of cognitive deficits in adults with a diagnosis of schizophrenia . Neuropsychology Review , 15 ( 2 ) : 73 – 95 . doi: 10.1007/s11065-005-6254-9
   PubMed Web of Science ®Google Scholar
• Fowler , I. L. , Carr , V. J. , Carter , N. T. and Lewin , T. J. 1998 . Patterns of current and lifetime substance use in schizophrenia . Schizophrenia Bulletin , 24 ( 3 ) : 443 – 455 . Retrieved from http://schizophreniabulletin.oxfordjournals.org/
   PubMed Web of Science ®Google Scholar
• Friedman , J. I. 2004 . Cholinergic targets for cognitive enhancement in schizophrenia: Focus on cholinesterase inhibitors and muscarinic agonists . Psychopharmacology , 174 ( 1 ) : 45 – 53 . doi: 10.1007/s00213-004-1794-x
   PubMed Web of Science ®Google Scholar
• Friedman , J. I. , Adler , D. N. , Temporini , H. D. , Kemether , E. , Harvey , P. D. , White , L. and Davis , K. L. 2001 . Guanfacine treatment of cognitive impairment in schizophrenia . Neuropsychopharmacology , 25 ( 3 ) : 402 – 409 . doi: 10.1016/S0893-133X(01)00249-4
   PubMed Web of Science ®Google Scholar
• Goff , D. C. , Lamberti , J. S. , Leon , A. C. , Green , M. F. , Miller , A. L. , Patel , J. and Johnson , S. A. 2008 . A placebo-controlled add-on trial of the ampakine, CX516, for cognitive deficits in schizophrenia . Neuropsychopharmacology , 33 ( 3 ) : 465 – 472 . doi: 10.1038/sj.npp. 1301444
   PubMed Web of Science ®Google Scholar
• Goldberg , T. E. , Hyde , T. M. , Kleinman , J. E. and Weinberger , D. R. 1993 . Course of schizophrenia: Neuropsychological evidence for a static encephalopathy . Schizophrenia Bulletin , 19 ( 4 ) : 797 – 804 . Retrieved from http://schizophreniabulletin.oxfordjournals.org/
   PubMed Web of Science ®Google Scholar
• Gomar , B. B. , Bobes-Bascaran , M. T. , Conejero-Goldberg , C. , Davies , P. and Goldberg , T. E. 2011 . Alzheimer's Disease Neuroimaging Initiative. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's Disease Neuroimaging Initiative . Archives of General Psychiatry , 68 ( 9 ) : 961 – 969 . Retrieved from http://archpsyc.jamanetwork.com/journal.aspx
   PubMed Web of Science ®Google Scholar
• Green , A. I. 2006 . Treatment of schizophrenia and comorbid substance abuse: Pharmacologic approaches . Journal of Clinical Psychiatry , 7 : 31 – 35 . Retrieved from http://www.psychiatrist.com/
   Google Scholar
• Green , A. I. , Drake , R. E. , Brunette , M. F. and Noordsy , D. L. 2007 . Schizophrenia and co-occurring substance use disorder . American Journal of Psychiatry , 164 : 402 – 408 . Retrieved from http://ajp.psychiatryonline.org/article.aspx?articleID = 98015
   PubMed Web of Science ®Google Scholar
• Harvey , P. D. and McClure , M. M. 2006 . Pharmacological approaches to the management of cognitive dysfunction in schizophrenia . Drugs , 66 ( 11 ) : 1465 – 1473 . Retrieved from http://adisonline.com/drugs/pages/default.aspx
   PubMed Web of Science ®Google Scholar
• Heinrichs , R. W. and Zakzanis , K. K. 1998 . Neurocognitive deficit in schizophrenia: A quantitative review of the evidence . Neuropsychology , 12 ( 3 ) : 426 – 445 . Retrieved from http://www.apa.org/pubs/journals/neu/index.aspx
   PubMed Web of Science ®Google Scholar
• Homayoun , H. and Moghaddam , B. 2010 . Group 5 metabotropic glutamate receptors: Role in modulating cortical activity and relevance to cognition . European Journal of Pharmacology , 639 ( 1–3 ) : 33 – 39 . doi: 10.1016/j.ejphar.2009.12.042
   PubMed Web of Science ®Google Scholar
• Javitt , D. C. 2008 . Glycine transport inhibitors and the treatment of schizophrenia . Biological Psychiatry , 63 ( 1 ) : 6 – 8 . doi: 10.1016/j.biopsych.2007.09.017
   PubMed Web of Science ®Google Scholar
• Javitt , D. C. 2009 . Glycine transport inhibitors for the treatment of schizophrenia: Symptom and disease modification . Current Opinion in Drug Discovery and Development , 12 ( 4 ) : 468 – 478 . Retrieved from http://www.biomedcentral.com/curropindrugdiscovdevel/archive/
   PubMed Web of Science ®Google Scholar
• Kantrowitz , J. T. , Malhotra , A. K. , Cornblatt , B. A. , Silipo , G. , Balla , A. , Suckow , R. F. and Javitt , D. C. 2010 . High dose D-serine in the treatment of schizophrenia . Schizophrenia Research , 121 ( 1–3 ) : 125 – 130 . doi: 10.1016/j.schres.2010.05.012
   PubMed Web of Science ®Google Scholar
• Keefe , K. A. and Gerfen , C. R. 1999 . Local infusion of the (+/−)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione does not block D1 dopamine receptor-mediated increases in immediate early gene expression in the dopamine-depleted striatum . Neuroscience , 89 ( 2 ) : 491 – 504 . doi: 10.1016/S0306-4522(98)00327-3
   PubMed Web of Science ®Google Scholar
• Keefe , R. S. , Bilder , R. M. , Davis , S. M. , Harvey , P. D. , Palmer , B. W. , Gold , J. M. and Lieberman , J. A. 2007 . Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial . Archives of General Psychiatry , 64 ( 6 ) : 633 – 647 . Retrieved from http://archpsyc.ama-assn.org/
   PubMed Web of Science ®Google Scholar
• Kern , R. S. , Gold , J. M. , Dickenson , D. , Green , M. F. , Nuechterlein , K. H. , Baade , L. E. and Marder , S. R. 2011 . The MCCB impairment profile for schizophrenia outpatients: Results from the MATRICS psychometric and standardization study . Schizophrenia Research , 126 ( 1–3 ) : 124 – 131 . doi: 10.1016/j.schres.2010.11.008
   PubMed Web of Science ®Google Scholar
• Manning , V. , Betteridge , S. , Wanigaratne , S. , Best , D. , Strang , J. and Gossop , M. 2009 . Cognitive impairment in dual diagnosis inpatients with schizophrenia and alcohol use disorder . Schizophrenia Research , 114 ( 1–3 ) : 98 – 104 . Retrieved from http://dx.doi.org/10.1016/j.schres.2009.05.020
   PubMed Web of Science ®Google Scholar
• Manning , V. , Wanigaratne , S. , Best , D. , Strathdee , G. , Schrover , I. and Gossop , M. 2007 . Screening for cognitive functioning in psychiatric outpatients with schizophrenia, alcohol dependence, and dual diagnosis . Schizophrenia Research , 91 ( 1–3 ) : 151 – 158 . doi: 10.1016/j.schres.2006.11.019
   PubMed Web of Science ®Google Scholar
• Mathalon , D. H. , Pfefferbaum , A. , Lim , K. O. , Rosenbloom , M. J. and Sullivan , E. V. 2003 . Compounded brain volume deficits in schizophrenia-alcoholism comorbidity . Archives of General Psychiatry , 60 ( 3 ) : 245 – 252 . Retrieved from http://archpsyc.ama-assn.org/
   PubMed Web of Science ®Google Scholar
• McIntosh , C. , Kippen , V. , Hutcheson , F. and McIntosh , A. 2005 . Parenteral thiamine use in the prevention and treatment of Wernicke-Korsakoff syndrome . The Psychiatrist , 29 : 94 – 97 . doi: 10.1192/pb.29.3.94
   Google Scholar
• Mohamed , S. , Bondi , M. W. , Kasckow , J. W. , Golshan , S. and Jeste , D. V. 2006 . Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia . International Journal of Geriatric Psychiatry , 21 ( 8 ) : 711 – 718 . doi: 10.1002/gps. 1528
   PubMed Web of Science ®Google Scholar
• Moselhy , H. F. , Georgiou , G. and Kahn , A. 2001 . Frontal lobe changes in alcoholism: A review of the literature . Alcohol & Alcoholism , 36 ( 5 ) : 357 – 368 . doi: 10.1093/alcalc/36.5.357
   PubMed Web of Science ®Google Scholar
• Mueser , K. T. , Yarnold , P. R. , Levinson , D. F. , Singh , H. , Bellack , A. S. , Kee , K. and Yadalam , K. G. 1990 . Prevalence of substance abuse in schizophrenia: Demographic and clinical correlates . Schizophrenia Bulletin , 16 ( 1 ) : 31 – 56 . doi: 10.1093/schbul/16.1.31
   PubMed Web of Science ®Google Scholar
• Nixon , S. J. , Hallford , H. G. and Tivis , R. D. 1996 . Neurocognitive function in alcoholic, schizophrenic, and dually diagnosed patients . Psychiatry Research , 64 ( 1 ) : 35 – 45 . doi: 10.1016/0165-1781(96)02911-3
   PubMed Web of Science ®Google Scholar
• Nuechterlein , K. H. , Barch , D. M. , Gold , J. M. , Goldberg , T. E. , Green , M. F. and Heaton , R. K. 2004 . Identification of separable cognitive factors in schizophrenia . Schizophrenia Research , 72 ( 1 ) : 29 – 39 . doi: 10.1016/j.schres.2004.09.007
   PubMed Web of Science ®Google Scholar
• O’Donnell , C. J. , Rogers , B. N. , Bronk , B. S. , Bryce , B. K. , Coe , J. W. , Cook , K. K. and Zhang , L. 2010 . Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: Synthesis, SAR development, and in vivo efficacy in cognition models . Journal of Medical Chemistry , 53 ( 3 ) : 1222 – 1237 . Retrieved from http://pubs.acs.org/journal/jmcmar
   PubMed Web of Science ®Google Scholar
• Owens , S. F. , Rijsdijk , F. , Picchioni , M. M. , Stahl , D. , Nenadic , I. , Murray , R. M. and Toulopoulou , T. 2011 . Genetic overlap between schizophrenia and selective components of executive function . Schizophrenia Research , 127 ( 1–3 ) : 181 – 187 . doi: 10.1016/j.schres.2010.10.010
   PubMed Web of Science ®Google Scholar
• Pencer , A. and Addington , J. 2003 . Substance use and cognition in early psychosis . Journal of Psychiatry & Neuroscience , 28 ( 1 ) : 48 – 54 . Retrieved from http://www.cma.ca/jpn
   PubMed Web of Science ®Google Scholar
• Phillips , G. B. , Victor , M. , Adams , R. D. and Davidson , C. S. 1952 . A study of the nutritional defect in Wernicke's syndrome: The effect of a purified diet, thiamine, and other vitamins on the clinical manifestations . Journal of Clinical Investigation , 31 : 859 – 871 . doi: 10.1172/JCI102673
   PubMed Web of Science ®Google Scholar
• Purdon , S. E. , Labelle , A. and Boulay , L. 2001 . Neuropsychological change in schizophrenia after 6 weeks of clozapine . Schizophrenia Research , 48 ( 1 ) : 57 – 67 . doi: 10.1016/S0920-9964(00)00101-8
   PubMed Web of Science ®Google Scholar
• Radek , R. J. , Kohlhass , K. L. , Rueter , L. E. and Mohler , E. G. 2010 . Treating the cognitive deficits of schizophrenia with alpha4beta2 neuronal nicotinic receptor agonists . Current Pharmaceutical Design , 16 ( 3 ) : 309 – 322 . Retrieved from http://www.benthamscience.com/cpd/
   PubMed Web of Science ®Google Scholar
• Ralevski , E. , Balachandra , K. , Gueorguieva , R. , Limoncelli , D. and Petrakis , I. 2006 . Effects of naltrexone on cognition in a treatment study of patients with schizophrenia and comorbid alcohol dependence . Journal of Dual Diagnosis , 2 ( 4 ) : 53 – 69 . Retrieved from http://www.tandf.co.uk/journals/WJDD
   Google Scholar
• Ralevski , E. , O’Brien , E. , Jane , J. S. , Dean , E. , Dwan , R. , Edens , E. L. and Petrakis , I. 2011 . Treatment with acamprosate in patients with schizophrenia spectrum disorders and comorbid alcohol dependence . Journal of Dual Diagnosis , 7 ( 1 ) : 64 – 73 . Retrieved from http://dx.doi.org/10.1080/15504263.2011.569440
   PubMed Web of Science ®Google Scholar
• Ribeiz , S. R. , Bassitt , D. P. , Arrais , J. A. , Avila , R. , Steffens , D. C. and Bottino , C. M. 2010 . Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: A review and meta-analysis of the literature . CNS Drugs , 24 ( 4 ) : 303 – 317 . Retrieved from http://adisonline.com/cnsdrugs/Pages/default.aspx
   PubMed Web of Science ®Google Scholar
• Ringen , P. A. , Lagerberg , T. V. , Birkenaes , A. B. , Engh , J. A. , Faerden , A. , Jonsdootir , H. and Andreassen , O. A. 2007 . Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder . Psychological Medicine , 38 ( 9 ) : 1241 – 1249 . doi: 10.1017/S003329170700236X
   PubMed Web of Science ®Google Scholar
• Rosenbloom , M. J. , Pfefferbaum , A. and Sullivan , E. V. 2004 . Recovery of short-term memory and psychomotor speed but not postural stability with long-term sobriety in alcoholic women . Neuropsychology , 18 ( 3 ) : 589 – 597 . doi: 10.1037/0894-4105.18.3.589
   PubMed Web of Science ®Google Scholar
• Saxton , J. , Munro , C. A. , Butters , M. A. , Schramke , C. and McNeil , M. A. 2000 . Alcohol, dementia, and Alzheimer's disease: Comparison of neuropsychological profiles . Journal of Geriatric Psychiatry & Neurology , 13 : 141 – 149 . doi: 10.1177/089198870001300308
   PubMed Web of Science ®Google Scholar
• Sullivan , E. V. 2003 . Compromised pontocerebellar and cerebellothalamocortical systems: Speculations on their contributions to cognitive and motor impairment in nonamnesic alcoholism . Alcoholism: Clinical & Experimental Research , 27 ( 9 ) : 1409 – 1419 . doi: 10.1097/01.ALC.0000085586.91726.46
   PubMed Web of Science ®Google Scholar
• Sullivan , E. V. , Shear , P. K. , Zipursky , R. B. , Sagar , H. J. and Pfefferbaum , A. 1997 . Patterns of content, contextual, and working memory impairments in schizophrenia and nonamnesic alcoholism . Neuropsychology , 11 ( 2 ) : 195 – 206 . doi: 10.1037/0894-4105.11.2.195
   PubMed Web of Science ®Google Scholar
• Thoma , R. J. , Hanlon , F. M. , Miller , G. A. , Huang , M. , Weisend , M. P. , Sanchez , F. P. and Canive , J. M. 2006 . Neuropsychological and sensory gating deficits related to remote alcohol abuse history in schizophrenia . Journal of the International Neuropsychological Society , 12 ( 3 ) : 34 – 44 . doi: 10.10170S1355617706060097
   Google Scholar
• Tsuang , J. W. , Eckman , T. E. , Shaner , A. and Marder , S. R. 1999 . Clozapine for substance-abusing schizophrenic patients . American Journal of Psychiatry , 156 ( 7 ) : 1119 – 1120 . Retrieved from http://ajp.psychiatryonline.org/journal.aspx?journalid = 13
   PubMed Web of Science ®Google Scholar
• Weingartner , H. G. , Andreason , P. J. , Hommer , D. , Sirocco , K. Y. , Rio , D. E. , Ruttiman , U. E. and Eckardt , M. J. 1996 . Monitoring the source of memory in detoxified alcoholics . Biological Psychiatry , 40 : 43 – 53 . doi: 10.1016/0006-3223(95)00290-1
   PubMed Web of Science ®Google Scholar